Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity
- 17 October 2009
- journal article
- Published byĀ ElsevierĀ inĀ Journal of Controlled Release
- Vol.Ā 142 Ā (2) , 187-195
- https://doi.org/10.1016/j.jconrel.2009.10.013
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Microneedle-Based VaccinesPublished by Springer Nature ,2009
- Effect of Early versus Deferred Antiretroviral Therapy for HIV on SurvivalNew England Journal of Medicine, 2009
- Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical modelThe Lancet, 2009
- Estimation of HIV Incidence in the United StatesJAMA, 2008
- Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trialThe Lancet, 2008
- Effect of Herpes Simplex Suppression on Incidence of HIV among Women in TanzaniaNew England Journal of Medicine, 2008
- Development of Stable Influenza Vaccine Powder Formulations: Challenges and PossibilitiesPharmaceutical Research, 2008
- Coated microneedles for transdermal deliveryPublished by Elsevier ,2006
- Influenza-Associated Hospitalizations in the United StatesJAMA, 2004
- The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B virusesEpidemiology and Infection, 1972